EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
1-Year Return
51.18%
This Quarter Return
+7.26%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$2.14B
AUM Growth
+$234M
(+12%)
Cap. Flow
+$180M
Cap. Flow
% of AUM
8.41%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
153
New
13
Increased
61
Reduced
17
Closed
9
Top Buys
| 1 |
GTT
GTT Communications, Inc.
GTT
|
$22.6M |
| 2 |
Varonis Systems
VRNS
|
$18.8M |
| 3 |
Arista Networks
ANET
|
$16.9M |
| 4 |
Roper Technologies
ROP
|
$16.6M |
| 5 |
HubSpot
HUBS
|
$15.4M |
Top Sells
| 1 |
Trade Desk
TTD
|
$16.3M |
| 2 |
Twilio
TWLO
|
$9.47M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$6.46M |
| 4 |
AKCA
Akcea Therapeutics, Inc. Common Stock
AKCA
|
$6.27M |
| 5 |
Protagonist Therapeutics
PTGX
|
$5.72M |
Sector Composition
| 1 | Healthcare | 38.18% |
| 2 | Technology | 17.61% |
| 3 | Consumer Discretionary | 12.18% |
| 4 | Industrials | 9.62% |
| 5 | Utilities | 3.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Roper Technologies
ROP
$56.7B
| $16.6M | 0.78% |
+59,000
| New | +$16.6M |
|
|
AY
52
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $16.2M | 0.76% |
827,500
+22,000
| +3% | +$431K |
|
53
Wave Life Sciences
WVE
$1.3B
| $15.2M | 0.71% |
378,000
-55,500
| -13% | -$2.23M |
|
54
Cirrus Logic
CRUS
$5.92B
| $15M | 0.7% |
370,000
| – | – |
|
55
Agios Pharmaceuticals
AGIO
$2.1B
| $14.6M | 0.68% |
178,000
-36,000
| -17% | -$2.94M |
|
56
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.49B
| $14.1M | 0.66% |
724,000
+26,800
| +4% | +$523K |
|
|
BPMC
57
DELISTED
Blueprint Medicines
BPMC
| $13.8M | 0.64% |
150,000
| – | – |
|
58
Voyager Therapeutics
VYGR
$215M
| $13.2M | 0.62% |
703,425
| – | – |
|
59
Neurocrine Biosciences
NBIX
$13.9B
| $12.9M | 0.61% |
156,000
| – | – |
|
60
Vulcan Materials
VMC
$38.6B
| $12.6M | 0.59% |
110,000
| – | – |
|
|
61
Twilio
TWLO
$16.3B
| $12.5M | 0.58% |
327,000
-248,000
| -43% | -$9.47M |
|
|
MYOV
62
DELISTED
Myovant Sciences Ltd.
MYOV
| $12.2M | 0.57% |
573,553
+21,453
| +4% | +$456K |
|
63
Veracyte
VCYT
$2.48B
| $11.9M | 0.56% |
2,133,500
| – | – |
|
|
ZGNX
64
DELISTED
Zogenix, Inc.
ZGNX
| $10.6M | 0.5% |
265,000
+97,000
| +58% | +$3.88M |
|
|
DOOR
65
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $10.4M | 0.49% |
170,000
| – | – |
|
66
Paycom
PAYC
$12.6B
| $10.3M | 0.48% |
96,000
+77,618
| +422% | +$8.34M |
|
67
Fennec Pharmaceuticals
FENC
$247M
| $8.96M | 0.42% |
741,175
| – | – |
|
|
BHVN
68
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $8.91M | 0.42% |
346,000
+104,000
| +43% | +$2.68M |
|
69
KalVista Pharmaceuticals
KALV
$765M
| $8.53M | 0.4% |
900,000
+191,000
| +27% | +$1.81M |
|
|
BOLD
70
DELISTED
Audentes Therapeutics, Inc
BOLD
| $8.11M | 0.38% |
270,000
+45,000
| +20% | +$1.35M |
|
71
argenx
ARGX
$44.9B
| $8.04M | 0.38% |
+100,000
| New | +$8.04M |
|
72
Tesla
TSLA
$1.09T
| $7.98M | 0.37% |
450,000
| – | – |
|
73
InflaRx
IFRX
$106M
| $7.93M | 0.37% |
275,000
| – | – |
|
74
Regeneron Pharmaceuticals
REGN
$60.1B
| $7.92M | 0.37% |
23,000
+15,500
| +207% | +$5.34M |
|
75
uniQure
QURE
$973M
| $7.87M | 0.37% |
+335,000
| New | +$7.87M |
|